Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter C Taylor

Showing results (51-60 of 246) with videos related to

Pageof 25
Sort By:
Pathology|August 22, 2017
A novel method to enable PCR testing of bacterial isolates in the BacT/ALERT Microbial Detection SystemChristopher J McIver, Noel Er, Robert Stevens, et al.
Pathology|September 10, 2024
Mutations of cysB in urinary isolates of cysteine-requiring Escherichia coliRyanbi Pratama, Peter C Taylor, Chinmoy Mukerjee, et al.
Frontiers in Pharmacology|April 16, 2019
Biological Therapies in Immune-Mediated Inflammatory Diseases: Can Biosimilars Reduce Access Inequities?Daniel C Baumgart, Laurent Misery, Sue Naeyaert, et al.
Pathology|September 17, 2004
Isolation and identification of Burkholderia cepacia by participants in an external Quality Assurance Program (QAP) between 1994 and 1999Peter C Taylor, Mary-Louise McLaws, Margot De Borde, et al.
Rheumatology International|January 10, 2016
A structured literature review of the burden of illness and unmet needs in patients with rheumatoid arthritis: a current perspectivePeter C Taylor, Adam Moore, Radu Vasilescu, et al.
Pathology|August 22, 2017
A novel quantitative PCR assay for testing bacteria directly from plate cultures using SYBR Green technologyChristopher J McIver, Felicia A Tjandra, Noel Er, et al.
The Journal of Nutrition|July 5, 2002
Immune functions are maintained in healthy men with low zinc intakeKathryn Pinna, Darshan S Kelley, Peter C Taylor, et al.
The Lancet. Rheumatology|October 17, 2025
The relationship between clinical disease activity, synovial inflammatory profile, and treatment response in rheumatoid arthritisClément Triaille, Patrick Durez, Francesco Natalucci, et al.
Rheumatology and Therapy|January 11, 2023
Outcomes Following Adalimumab Bio-originator to Biosimilar Switch-A Comparison Using Real-world Patient- and Physician-Reported Data in European CountriesPeter C Taylor, Yuri Sanchez Gonzalez, Ryan Clark, et al.
Lancet (London, England)|May 27, 2015
Spondyloarthropathy: interleukin 23 and disease modificationJonathan P Sherlock, Peter C Taylor, Christopher D Buckley, et al.
Pageof 25

Showing results (51-60 of 246) with videos related to

Sort By:
Pageof 25
Pathology|August 22, 2017
A novel method to enable PCR testing of bacterial isolates in the BacT/ALERT Microbial Detection SystemChristopher J McIver, Noel Er, Robert Stevens, et al.
Pathology|September 10, 2024
Mutations of cysB in urinary isolates of cysteine-requiring Escherichia coliRyanbi Pratama, Peter C Taylor, Chinmoy Mukerjee, et al.
Frontiers in Pharmacology|April 16, 2019
Biological Therapies in Immune-Mediated Inflammatory Diseases: Can Biosimilars Reduce Access Inequities?Daniel C Baumgart, Laurent Misery, Sue Naeyaert, et al.
Pathology|September 17, 2004
Isolation and identification of Burkholderia cepacia by participants in an external Quality Assurance Program (QAP) between 1994 and 1999Peter C Taylor, Mary-Louise McLaws, Margot De Borde, et al.
Rheumatology International|January 10, 2016
A structured literature review of the burden of illness and unmet needs in patients with rheumatoid arthritis: a current perspectivePeter C Taylor, Adam Moore, Radu Vasilescu, et al.
Pathology|August 22, 2017
A novel quantitative PCR assay for testing bacteria directly from plate cultures using SYBR Green technologyChristopher J McIver, Felicia A Tjandra, Noel Er, et al.
The Journal of Nutrition|July 5, 2002
Immune functions are maintained in healthy men with low zinc intakeKathryn Pinna, Darshan S Kelley, Peter C Taylor, et al.
The Lancet. Rheumatology|October 17, 2025
The relationship between clinical disease activity, synovial inflammatory profile, and treatment response in rheumatoid arthritisClément Triaille, Patrick Durez, Francesco Natalucci, et al.
Rheumatology and Therapy|January 11, 2023
Outcomes Following Adalimumab Bio-originator to Biosimilar Switch-A Comparison Using Real-world Patient- and Physician-Reported Data in European CountriesPeter C Taylor, Yuri Sanchez Gonzalez, Ryan Clark, et al.
Lancet (London, England)|May 27, 2015
Spondyloarthropathy: interleukin 23 and disease modificationJonathan P Sherlock, Peter C Taylor, Christopher D Buckley, et al.
Pageof 25